Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1953 Feb;65(2):171–176. doi: 10.1128/jb.65.2.171-176.1953

PATHOGENESIS OF CANDIDA ALBICANS INFECTION FOLLOWING ANTIBIOTIC THERAPY I.

The Effect of Antibiotics on the Growth of Candida albicans

M Huppert 1, D A MacPherson 1, J Cazin 1
PMCID: PMC169661  PMID: 13034711

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIERMAN H. R., JAWETZ E. The effect of prolonged administration of antibiotics of the human fecal flora. J Lab Clin Med. 1951 Mar;37(3):394–401. [PubMed] [Google Scholar]
  2. DEARING W. H., HEILMAN F. R. The effect of antibacterial agents on the intestinal flora of patients: the use of aureomycin, chloromycetin, dihydrostreptomycin, sulfasuxidine and sulfathalidine. Gastroenterology. 1950 Sep;16(1):12–18. [PubMed] [Google Scholar]
  3. FINLAND M. The present status of antibiotics in bacterial infections. Bull N Y Acad Med. 1951 Apr;27(4):199–220. [PMC free article] [PubMed] [Google Scholar]
  4. FOLEY G. E., WINTER W. D., Jr Increased mortality following penicillin therapy of chick embryos infected with Candida albicans var. stellatoidea. J Infect Dis. 1949 Nov-Dec;85(3):268–274. doi: 10.1093/infdis/85.3.268. [DOI] [PubMed] [Google Scholar]
  5. GARROD L. P. The reactions of bacteria to chemotherapeutic agents. Br Med J. 1951 Feb 3;1(4700):205–210. doi: 10.1136/bmj.1.4700.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HARRIS H. J. Aureomycin and chloramphenicol in brucellosis; with special reference to side effects. J Am Med Assoc. 1950 Jan 21;142(3):161–165. doi: 10.1001/jama.1950.02910210017005. [DOI] [PubMed] [Google Scholar]
  7. KEEFER C. S. Alterations in normal bacterial flora of man and secondary infections during antibiotic therapy. Am J Med. 1951 Dec;11(6):665–666. doi: 10.1016/0002-9343(51)90017-4. [DOI] [PubMed] [Google Scholar]
  8. MARSHALL H. C., Jr, PALMER W. L., KIRSNER J. B. Effects of chemotherapeutic agents on fecal bacteria in patients with chronic ulcerative colitis. J Am Med Assoc. 1950 Nov 11;144(11):900–903. doi: 10.1001/jama.1950.02920110012004. [DOI] [PubMed] [Google Scholar]
  9. METZGER W. I., SHAPSE J. B. Evaluation of oral aureomycin for intestinal antisepsis. J Bacteriol. 1950 Feb;59(2):309–310. doi: 10.1128/jb.59.2.309-310.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MILLER C. P. New problems in the treatment of infectious diseases. Ann Intern Med. 1951 Oct;35(4):763–770. doi: 10.7326/0003-4819-35-4-763. [DOI] [PubMed] [Google Scholar]
  11. MOORE M. In vivo and in vitro effect of aureomycin hydrochloride on Syringospora (Monilia, Candida) albicans. J Lab Clin Med. 1951 May;37(5):703–712. [PubMed] [Google Scholar]
  12. McVAY L. V., Jr, SPRUNT D. H. A study of moniliasis in aureomycin therapy. Proc Soc Exp Biol Med. 1951 Dec;78(3):759–761. doi: 10.3181/00379727-78-19209. [DOI] [PubMed] [Google Scholar]
  13. PAPPENFORT R. B., SCHNALL E. S. Moniliasis in patients treated with aureomycin; clinical and laboratory evidence that aureomycin stimulates the growth of Candida albicans. AMA Arch Intern Med. 1951 Dec;88(6):729–735. doi: 10.1001/archinte.1951.03810120030002. [DOI] [PubMed] [Google Scholar]
  14. Spaulding E. H., Madajewski D. S., Rowe R. J., Bacon H. E. THE EFFECT OF ORALLY ADMINISTERED STREPTOMYCIN AND SULFATHALIDINE UPON THE BACTERIAL FLORA OF THE COLON. J Bacteriol. 1949 Sep;58(3):279–289. [PMC free article] [PubMed] [Google Scholar]
  15. WELCH H. Absorption, excretion, and distribution of terramycin. Ann N Y Acad Sci. 1950 Sep;53(2):253–265. doi: 10.1111/j.1749-6632.1950.tb42157.x. [DOI] [PubMed] [Google Scholar]
  16. WOODS J. W., MANNING I. H., Jr, PATTERSON C. N. Monilial infections complicating the therapeutic use of antibiotics. J Am Med Assoc. 1951 Jan 27;145(4):207–211. doi: 10.1001/jama.1951.02920220015003. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES